logo

For the Inventor, By the Inventor

Roseland, NJ, United States of America

Emisphere Technologies, Inc.


USPTO Granted Patents = 183

% Expired Patents = 39.3



Trademarks = 2

Forward Citations = 5,315

Loading Chart...
Loading Chart...

117 inventors (with patents filed for the assignee):

goldMedal Andrea Leone-Bay (68 out of 118 patents)

silverMedal Sam J Milstein (52 out of 53 patents)

bronzeMedal Donald J Sarubbi (44 out of 45 patents)

4.  David Gschneidner (26 out of 29 patents)

5.  Shingai Majuru (24 out of 28 patents)

6.  Koc-Kan Ho (24 out of 50 patents)

7.  Nai Fang Wang (21 out of 21 patents)

8.  Evgueni N Barantsevitch (19 out of 19 patents)

9.  Eric Yanjun Wang (19 out of 24 patents)

10.  Harry R Leipold (18 out of 19 patents)

11.  Pingwah Tang (15 out of 15 patents)

12.  Steven Minh Dinh (14 out of 18 patents)

13.  Doris C O'Toole (12 out of 15 patents)

14.  Michael M Goldberg (12 out of 13 patents)

15.  Martin L Kantor (12 out of 16 patents)


Core Competencies:
GLP-1 Formulations
Insulin Therapies
Active Agent Compounds
Oral Delivery
Pharmaceutical Formulations
Polymorphic Forms
Salcaprozate Sodium
Cromolyn Sodium
Bisphosphonates
Calcium Disorders
Phenoxy Compounds
Aryl Ketone Compounds

183 patents:

1. 10875826 - Process for the manufacture of SNAC (salcaprozate sodium) (2020-12-29),
2. RE48164 - Compounds and compositions for delivering active agents (2020-08-17),
3. 10744105 - Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate (2020-08-18),
4. 10456472 - Phenylalkylcarboxylic acid delivery agents (2019-10-29),
5. 10188621 - Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate (2019-01-29),
6. 9873667 - Arylsulfanyl compounds and compositions for delivering active agents (2018-01-23),
7. 9750710 - Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate (2017-09-05),
8. 9498487 - Topical cromolyn formulations (2016-11-22),
9. 9458089 - Phenoxy alkyl diethanolamine and diisopropanolamine compounds for delivering active agents (2016-10-04),
10. 9402864 - Oral iron deficiency therapy (2016-08-02),
11. 9399054 - Compositions for delivering peptide YY and PYY agonists (2016-07-26),
12. 9370492 - Solid pharmaceutical dosage forms comprising bisphosphonates and modified amino acid carriers (2016-06-21),
13. 9364502 - Gallium nitrate formulations (2016-06-14),
14. 9345725 - Pharmaceutical formulations of gallium salts (2016-05-24),
15. 9345722 - Pharmaceutical formulations for the treatment of alzheimer's disease (2016-05-24),
Emisphere Technologies, Inc. is a biopharmaceutical company based in Roseland, NJ, specializing in innovative drug delivery systems. The company focuses on developing advanced formulations for therapeutic agents, particularly in the realm of GLP-1 and insulin therapies. Emisphere's proprietary technologies enable oral delivery of active compounds, enhancing the bioavailability and effectiveness of pharmaceutical formulations. Their research encompasses polymorphic forms and specific compounds like Salcaprozate Sodium and Cromolyn Sodium, aiming to improve patient outcomes in diabetes and other conditions.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Emisphere Technologies, Inc.
183 Patents

#2 in Roseland, NJ

#100 in New Jersey

#2,220 in US

#4,560 in the World

Roseland, NJ (US)
Roseland, NJ, United States of America

Emisphere Technologies, Inc.

Forward Citations = 5,315

117 inventors:

goldMedal Andrea Leone-Bay (68 out of 118 patents)

silverMedal Sam J Milstein (52 out of 53 patents)

bronzeMedal Donald J Sarubbi (44 out of 45 patents)

4.  David Gschneidner (26 out of 29 patents)

5.  Shingai Majuru (24 out of 28 patents)

Please report any incorrect information to [email protected]
Loading…